| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2002;74:227-231
© 2002 The Society of Thoracic Surgeons
a Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
b Department of Oncology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
* Address reprint requests to Dr Heitmiller, 3333 N Calvert St, Johnston Professional Building, Ste 610, Union Memorial Hospital, Baltimore, MD 21218-2895 USA
e-mail: richardhe{at}helix.org
Presented at the Forty-eighth Annual Meeting of the Southern Thoracic Surgical Association, San Antonio, TX, Nov 8–10, 2001.
Background. Data suggest that preoperative chemoradiation improves survival in patients with stage II and III esophageal tumors. Whether preoperative therapy increases postesophagectomy morbidity and mortality has not been determined. This study evaluates our postoperative results after chemoradiation therapy.
Methods. From 1989 through 1998, 120 consecutive patients underwent chemoradiation therapy followed by esophagectomy at our institution. The medical records for these patients were reviewed to determine patient age, sex, race, cell type, operative technique, complications, deaths, and length of hospital stay (LOS).
Results. There were 106 (88%) men and 14 (12%) women with a mean age of 58 (32 to 77) years. White patients predominated (114 of 120, 95%); 98 (82%) had adenocarcinoma and 22 (18%) had squamous cell carcinoma. Operative technique was transhiatal in 91 (76%) patients, three-incision in 23 (19%), Ivor-Lewis in 4 (3%), and thoracoabdominal in 2 (2%). There was 1 death. Complications developed in 44 (37%) patients; 59% (13 of 22) of squamous cell carcinoma patients and 32% (31 of 98) of adenocarcinoma patients developed complications. Respiratory complications occurred in 32% (7 of 22) of squamous cell carcinoma patients and in 3% (3 of 98) of adenocarcinoma patients. Mean length of stay after surgery was 15 days (range 7 to 163).
Conclusions. Postesophagectomy results after chemoradiation therapy are comparable to those reported after esophagectomy alone. Squamous cell carcinoma patients are nearly twice as likely to develop postoperative complications and are more likely to have respiratory complications than adenocarcinoma patients.
This article has been cited by other articles:
|
|
 |
|
  E. C. Paulson, J. Ra, K. Armstrong, C. Wirtalla, F. Spitz, and R. R. Kelz Underuse of Esophagectomy as Treatment for Resectable Esophageal Cancer Arch Surg, December 1, 2008; 143(12): 1198 - 1203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. B. D'Journo, P. Michelet, L. Papazian, M. Reynaud-Gaubert, C. Doddoli, R. Giudicelli, P. A. Fuentes, and P. A. Thomas Airway colonisation and postoperative pulmonary complications after neoadjuvant therapy for oesophageal cancer Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 444 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shaw Genetics of postoperative complications following thoracic surgery. Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 327 - 345. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Tsujimoto, S. Ono, K. Chochi, H. Sugasawa, T. Ichikura, and H. Mochizuki Preoperative Chemoradiotherapy for Esophageal Cancer Enhances the Postoperative Systemic Inflammatory Response Jpn. J. Clin. Oncol., October 1, 2006; 36(10): 632 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shiraishi, K. Kawahara, T. Shirakusa, S. Yamamoto, and T. Maekawa Risk Analysis in Resection of Thoracic Esophageal Cancer in the Era of Endoscopic Surgery. Ann. Thorac. Surg., March 1, 2006; 81(3): 1083 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Abou-Jawde, T. Mekhail, D. J. Adelstein, L. A. Rybicki, P. J. Mazzone, M. A. Caroll, and T. W. Rice Impact of Induction Concurrent Chemoradiotherapy on Pulmonary Function and Postoperative Acute Respiratory Complications in Esophageal Cancer Chest, July 1, 2005; 128(1): 250 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Rice, A. M. Correa, A. A. Vaporciyan, N. Sodhi, W. R. Smythe, S. G. Swisher, G. L. Walsh, J. B. Putnam Jr, R. Komaki, J. A. Ajani, et al. Preoperative Chemoradiotherapy Prior to Esophagectomy in Elderly Patients is Not Associated With Increased Morbidity Ann. Thorac. Surg., February 1, 2005; 79(2): 391 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Crestanello, C. Deschamps, S. D. Cassivi, F. C. Nichols III, M. S. Allen, C. Schleck, and P. C. Pairolero Selective management of intrathoracic anastomotic leak after esophagectomy J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 254 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. C.-F. Lin, A. E. Durkin, and M. K. Ferguson Induction Therapy Does Not Increase Surgical Morbidity After Esophagectomy for Cancer Ann. Thorac. Surg., November 1, 2004; 78(5): 1783 - 1789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Mariette, G. Taillier, I. Van Seuningen, and J.-P. Triboulet Factors Affecting Postoperative Course and Survival After En Bloc Resection for Esophageal Carcinoma Ann. Thorac. Surg., October 1, 2004; 78(4): 1177 - 1183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Cerfolio, A. S. Bryant, C. S. Bass, J. R. Alexander, and A. A. Bartolucci Fast Tracking After Ivor Lewis Esophagogastrectomy Chest, October 1, 2004; 126(4): 1187 - 1194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Heitmiller Invited commentary Ann. Thorac. Surg., January 1, 2004; 77(1): 265 - 265. [Full Text] [PDF]
|
|
|
|
|
|
O. Hagry, W. Coosemans, P. De Leyn, P. Nafteux, D. Van Raemdonck, E. Van Cutsem, K. Hausterman, and T. Lerut Effects of preoperative chemoradiotherapy on postsurgical morbidity and mortality in cT3-4 +/- cM1lymph cancer of the oesophagus and gastro-oesophageal junction Eur. J. Cardiothorac. Surg., August 1, 2003; 24(2): 179 - 186. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
